290 related articles for article (PubMed ID: 10516340)
1. Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?
Ponticelli C; Villa M; Banfi G; Cesana B; Pozzi C; Pani A; Passerini P; Farina M; Grassi C; Baroli A
Am J Kidney Dis; 1999 Oct; 34(4):618-25. PubMed ID: 10516340
[TBL] [Abstract][Full Text] [Related]
2. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study.
Banfi G; Moriggi M; Sabadini E; Fellin G; D'Amico G; Ponticelli C
Clin Nephrol; 1991 Aug; 36(2):53-9. PubMed ID: 1934660
[TBL] [Abstract][Full Text] [Related]
3. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
Dumoulin A; Hill GS; Montseny JJ; Meyrier A
Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
[TBL] [Abstract][Full Text] [Related]
4. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants.
Chun MJ; Korbet SM; Schwartz MM; Lewis EJ
J Am Soc Nephrol; 2004 Aug; 15(8):2169-77. PubMed ID: 15284302
[TBL] [Abstract][Full Text] [Related]
5. [Primary focal segmental glomerulosclerosis in adults: response to treatment and outcome].
Niang A; Hachim K; Zahiri K; Fatihi E; Benghanem M; Ramdani B; Sqalli S; Zaid D
Dakar Med; 2004; 49(1):13-6. PubMed ID: 15782470
[TBL] [Abstract][Full Text] [Related]
6. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[TBL] [Abstract][Full Text] [Related]
8. Clinical course of primary focal segmental glomerulosclerosis (FSGS) in Turkish children: a report from the Turkish Pediatric Nephrology FSGS Study Group.
Beşbaş N; Ozaltin F; Emre S; Anarat A; Alpay H; Bakkaloğlu A; Baskin E; Buyan N; Dönmez O; Düşünsel R; Ekim M; Göko F; Gür-Güven A; Kavukçu S; Mir S; Sönmez F
Turk J Pediatr; 2010; 52(3):255-61. PubMed ID: 20718182
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year follow-up study.
Goumenos DS; Tsagalis G; El Nahas AM; Shortland JR; Davlouros P; Vlachojannis JG; Brown CB
Nephron Clin Pract; 2006; 104(2):c75-82. PubMed ID: 16785738
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
11. Duration of optimal therapy for idiopathic focal segmental glomerulosclerosis.
Pokhariyal S; Gulati S; Prasad N; Sharma RK; Singh U; Gupta RK; Mittal S; Mehta B
J Nephrol; 2003; 16(5):691-6. PubMed ID: 14733415
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose.
Chishti AS; Sorof JM; Brewer ED; Kale AS
Am J Kidney Dis; 2001 Oct; 38(4):754-60. PubMed ID: 11576878
[TBL] [Abstract][Full Text] [Related]
13. Treatment of membranous lupus nephritis.
Moroni G; Maccario M; Banfi G; Quaglini S; Ponticelli C
Am J Kidney Dis; 1998 Apr; 31(4):681-6. PubMed ID: 9531186
[TBL] [Abstract][Full Text] [Related]
14. Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glomerulosclerosis: a pilot study.
Bazzi C; Petrini C; Rizza V; Napodano P; Paparella M; Arrigo G; Pisano L; D'Amico G
Am J Kidney Dis; 2003 Feb; 41(2):328-35. PubMed ID: 12552493
[TBL] [Abstract][Full Text] [Related]
15. Clinical and morphological predictors of renal outcome in adult patients with focal and segmental glomerulosclerosis (FSGS).
Shiiki H; Nishino T; Uyama H; Kimura T; Nishimoto K; Iwano M; Kanauchi M; Fujii Y; Dohi K
Clin Nephrol; 1996 Dec; 46(6):362-8. PubMed ID: 8982551
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic correlates predict the outcome in children with steroid-resistant idiopathic nephrotic syndrome treated with pulse methylprednisolone therapy.
Kirpekar R; Yorgin PD; Tune BM; Kim MK; Sibley RK
Am J Kidney Dis; 2002 Jun; 39(6):1143-52. PubMed ID: 12046024
[TBL] [Abstract][Full Text] [Related]
18. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal.
Geary DF; Farine M; Thorner P; Baumal R
Clin Nephrol; 1984 Sep; 22(3):109-13. PubMed ID: 6488594
[TBL] [Abstract][Full Text] [Related]
19. Changing trends of histopathology in childhood nephrotic syndrome.
Gulati S; Sharma AP; Sharma RK; Gupta A
Am J Kidney Dis; 1999 Oct; 34(4):646-50. PubMed ID: 10516344
[TBL] [Abstract][Full Text] [Related]
20. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
Thorne JE; Woreta FA; Jabs DA; Anhalt GJ
Ophthalmology; 2008 Dec; 115(12):2146-2152.e1. PubMed ID: 18930554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
